Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV).
Studies of the number of cases where human immunodeficiency virus (HIV) is present in a specific population at a designated time. The presence in a given individual is determined by the finding of HIV antibodies in the serum (HIV SEROPOSITIVITY).
Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
Abuse, overuse, or misuse of a substance by its injection into a vein.
Sexual activities of humans.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases.
Immunoglobulins produced in response to VIRAL ANTIGENS.
Immunoglobulins produced in a response to BACTERIAL ANTIGENS.
A species of CHLAMYDOPHILA that causes acute respiratory infection, especially atypical pneumonia, in humans, horses, and koalas.
Infections with bacteria of the genus CHLAMYDOPHILA.
The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.
Diagnostic procedures involving immunoglobulin reactions.
An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.
Immune status consisting of non-production of HIV antibodies, as determined by various serological tests.
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405).
Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
Infection by round worms of the genus TOXOCARA, usually found in wild and domesticated cats and dogs and foxes, except for the larvae, which may produce visceral and ocular larva migrans in man.
Immunoglobulins produced in a response to PROTOZOAN ANTIGENS.
Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.
The acquired form of infection by Toxoplasma gondii in animals and man.
An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.
A genus of ascarid nematodes commonly parasitic in the intestines of cats and dogs.
A species of SIMPLEXVIRUS associated with genital infections (HERPES GENITALIS). It is transmitted by sexual intercourse and close personal contact.
Immunologic tests for identification of HIV (HTLV-III/LAV) antibodies. They include assays for HIV SEROPOSITIVITY and HIV SERONEGATIVITY that have been developed for screening persons carrying the viral antibody from patients with overt symptoms of AIDS or AIDS-RELATED COMPLEX.
The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte.
'Blood donors' are individuals who voluntarily and safely donate a specific amount of their own blood, which can be further separated into components, to be used for transfusion purposes or for manufacturing medical products, without receiving remuneration that is intended to reward them financially.
INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
A genus of protozoan parasites of the subclass COCCIDIA. Its species are parasitic in dogs, cattle, goats, and sheep, among others. N. caninum, a species that mainly infects dogs, is intracellular in neural and other cells of the body, multiplies by endodyogeny, has no parasitophorous vacuole, and has numerous rhoptries. It is known to cause lesions in many tissues, especially the brain and spinal cord as well as abortion in the expectant mother.
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.
The inhabitants of rural areas or of small towns classified as rural.
A contagious venereal disease caused by the spirochete TREPONEMA PALLIDUM.
Infection of the genitals (GENITALIA) with HERPES SIMPLEX VIRUS in either the males or the females.
A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS.
A genus of protozoa parasitic to birds and mammals. T. gondii is one of the most common infectious pathogenic animal parasites of man.
Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions.
I'm sorry for any confusion, but "Brazil" is not a medical term or concept, it is a country located in South America, known officially as the Federative Republic of Brazil. If you have any questions related to health, medicine, or science, I'd be happy to help answer those!
The sexual attraction or relationship between members of the same SEX.

Tuberculous meningitis in South African urban adults. (1/3131)

We retrospectively reviewed 56 adults with culture-proven tuberculous meningitis (TBM), investigating clinical signs, cerebrospinal fluid (CSF) findings and outcome. There were 50 patients, aged 18-59 years, 39 with and 11 without human immunodeficiency virus (HIV) infection. Six were aged 60 years or older. Neurological signs of TBM in 18-59-year-olds were unaffected by HIV serostatus while, compared to those > or = 60 years of age, there were more patients with meningism (86.0% vs. 33.3%; p = 0.011) and fewer with seizures (12.0% vs. 50.0%; p = 0.046). The HIV-infected 18-59-year-olds had significantly more extrameningeal tuberculosis compared to the non-HIV-infected (76.9% vs. 9.1%; p = 0.0001) and 23.1% had 'breakthrough' TBM. CSF analysis revealed 12 patients (21.4%) with acellular fluid (more common in those > or = 60 years of age, p = 0.016), of whom three had completely normal CSF. A neutrophil predominance was found in 22 patients (39.3%). Only three patients (5.4%) had a positive CSF smear for acid-fast bacilli. In-hospital mortality occurred in 39 patients (69.1%), was similar in all study groups, and was not related to neurological stage. The diagnosis of TBM can be masked by lack of meningism in the elderly and by atypical CSF findings.  (+info)

Coalescent estimates of HIV-1 generation time in vivo. (2/3131)

The generation time of HIV Type 1 (HIV-1) in vivo has previously been estimated using a mathematical model of viral dynamics and was found to be on the order of one to two days per generation. Here, we describe a new method based on coalescence theory that allows the estimate of generation times to be derived by using nucleotide sequence data and a reconstructed genealogy of sequences obtained over time. The method is applied to sequences obtained from a long-term nonprogressing individual at five sampling occasions. The estimate of viral generation time using the coalescent method is 1.2 days per generation and is close to that obtained by mathematical modeling (1.8 days per generation), thus strengthening confidence in estimates of a short viral generation time. Apart from the estimation of relevant parameters relating to viral dynamics, coalescent modeling also allows us to simulate the evolutionary behavior of samples of sequences obtained over time.  (+info)

Cytokine profile induced by Cryptosporidium antigen in peripheral blood mononuclear cells from immunocompetent and immunosuppressed persons with cryptosporidiosis. (3/3131)

The proliferative response of peripheral blood mononuclear cells (PBMC) to a crude extract from Cryptosporidium parvum (CCE) was studied in persons who acquired cryptosporidiosis in the same outbreak (15 immunocompetent subjects with prior cryptosporidiosis and 22 human immunodeficiency virus [HIV]-positive persons with various levels of immunosuppression and active cryptosporidiosis) and in individual patients (8 HIV-positive patients with active cryptosporidiosis and 15 HIV-positive persons without history of cryptosporidiosis). PBMC from HIV-positive persons showed less proliferation to CCE and mitogens than did PBMC from immunocompetent subjects with prior cryptosporidiosis, independent of CD4 cell count. In immunocompetent subjects, cytokine gene expression was consistent with cytokine production, whereas in HIV-positive subjects it was not. The production of interferon-gamma in CCE-stimulated PBMC from both immunocompetent and HIV-positive subjects with cryptosporidiosis and the lack of interferon-gamma in CCE-stimulated PBMC from HIV-positive subjects without cryptosporidiosis indicate that C. parvum mainly induces a Th1 response.  (+info)

Cardiac autoimmunity in HIV related heart muscle disease. (4/3131)

OBJECTIVE: To assess the frequency of circulating cardiac specific autoantibodies in HIV positive patients with and without echocardiographic evidence of left ventricular dysfunction. SUBJECTS: 74 HIV positive patients including 28 with echocardiographic evidence of heart muscle disease, 52 HIV negative people at low risk of HIV infection, and 14 HIV negative drug users who had all undergone non-invasive cardiac assessment were studied along with a group of 200 healthy blood donors. RESULTS: Cardiac autoantibodies detected by indirect immunofluorescence (serum dilution 1/10) were more common in the HIV positive patients (15%), particularly the HIV heart muscle disease group (21%), than in HIV negative controls (3.5%) (both p < 0.001). By ELISA (dilution 1/320), abnormal anti-alpha myosin autoantibody concentrations were found more often in HIV patients with heart muscle disease (43%) than in HIV positive patients with normal hearts (19%) or in HIV negative controls (3%) (p < 0.05 and p < 0.001, respectively). Anti-alpha myosin autoantibody concentrations were greater in HIV positive patients than in HIV negative controls, regardless of cardiac status ((mean SD) 0.253 (0.155) v 0.170 (0.076); p = 0.003). In particular the mean antibody concentration was higher in the HIV heart muscle disease patients (0.291 (0.160) v 0.170 (0.076); p = 0.001) than in HIV negative controls. On follow up, six subjects with normal echocardiograms but raised autoantibody concentrations had died after a median of 298 days, three with left ventricular abnormalities at necropsy. This compared with a median survival of 536 days for 21 HIV positive patients with normal cardiological and immunological results. CONCLUSIONS: There is an increased frequency of circulating cardiac specific autoantibodies in HIV positive individuals, particularly those with heart muscle disease. The data support a role for cardiac autoimmunity in the pathogenesis of HIV related heart muscle disease, and suggest that cardiac autoantibodies may be markers of the development of left ventricular dysfunction in HIV positive patients with normal hearts.  (+info)

Voluntary newborn HIV-1 antibody testing: a successful model program for the identification of HIV-1-seropositive infants. (5/3131)

Harlem Hospital in New York City has one of the highest HIV-1 newborn seroprevalence rates in the United States. We report the results of a program introduced in 1993 and designed to identify HIV-1-seropositive (HIV+) newborns at birth. All new mothers, independent of risk, received HIV counseling that emphasized the medical imperative to know the infant's HIV status as well as their own. Consent was obtained to test the infant; discarded cord blood samples were tested by enzyme-linked immunosorbent assay (ELISA), and when positive, Western Blot confirmation. We compared the number of HIV+ infants identified through voluntary testing with the number reported by the anonymous New York State Newborn HIV Seroprevalence Study. In 1993, 97.8% (91 of 93) of the number of HIV+ infants identified by the anonymous testing were identified through voluntary maternal and newborn testing programs. Eighty-five HIV+ infants were identified before nursery discharge: 50% (42/85) through newborn testing; 14% (12/85) through prenatal testing; 13% (11/85) presented to care knowing their status; 23% (20/85) were known because of a previous HIV+ child. Six additional HIV+ children were diagnosed after hospital discharge (mean age, 5.5 months; range 1.5 through 17 months); four presented with symptomatic disease. The optimal time for identification of the HIV+ pregnant woman is before or during pregnancy, but when this does not occur, voluntary newborn testing can identify many HIV+ infants who would otherwise be discharged undiagnosed from the nursery.  (+info)

Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure. (6/3131)

A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw. The IFN-gamma release assay was compared with the standard tuberculin skin test (TST) among 467 intravenous drug users at risk for tuberculosis in urban Baltimore. Among 300 human immunodeficiency virus (HIV)-seronegative patients, the IFN-gamma release assay was positive in 177 (59%), whereas the TST was positive in 71 (24%), for a percent agreement of 59% (kappa=26%). Among 167 HIV-seropositive subjects, the IFN-gamma release assay identified 32 reactors (19%); the TST identified 16 reactors (9.6%), for a percent agreement of 82% (kappa=28%). The IFN-gamma release assay detected more reactors than did the TST, but its agreement with TST was weak. As the TST is an imperfect standard, further evaluation of the IFN-gamma release assay among uninfected persons and persons with culture-confirmed tuberculosis will be useful.  (+info)

Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts. (7/3131)

To assess possible differences in immune status, proportions and absolute numbers of subsets of CD4+ and CD8+ T cells were compared between HIV- healthy Ethiopians (n = 52) and HIV- Dutch (n = 60). Both proportions and absolute numbers of naive CD4+ and CD8+ T cells were found to be significantly reduced in HIV Ethiopians compared with HIV- Dutch subjects. Also, both proportions and absolute numbers of the effector CD8+ T cell population as well as the CD4+CD45RA-CD27- and CD8+CD45RA-CD27- T cell populations were increased in Ethiopians. Finally, both proportions and absolute numbers of CD4+ and CD8+ T cells expressing CD28 were significantly reduced in Ethiopians versus Dutch. In addition, the possible association between the described subsets and HIV status was studied by comparing the above 52 HIV- individuals with 32 HIV+ Ethiopians with CD4 counts > 200/microliter and/or no AIDS-defining conditions and 39 HIV+ Ethiopians with CD4 counts < 200/microliter or with AIDS-defining conditions. There was a gradual increase of activated CD4+ and CD8+ T cells, a decrease of CD8+ T cells expressing CD28 and a decrease of effector CD8+ T cells when moving from HIV- to AIDS. Furthermore, a decrease of naive CD8+ T cells and an increase of memory CD8+ T cells in AIDS patients were observed. These results suggest a generally and persistently activated immune system in HIV- Ethiopians. The potential consequences of this are discussed, in relation to HIV infection.  (+info)

Tissue specific HPV expression and downregulation of local immune responses in condylomas from HIV seropositive individuals. (8/3131)

OBJECTIVE: To study the effect of tissue specific human papillomavirus (HPV) expression and its effect on local immunity in condylomas from HIV positive individuals. METHODS: Biopsy specimens of eight penile and eight perianal condylomas from HIV seropositive individuals were analysed. Expression of viral genes (HIV-tat and HPV E7 and L1) was determined by RT-PCR. The status of local immunity also was determined by RT-PCR by measuring CD4, CD8, CD16, CD1a, HLA-DR, and HLA-B7 mRNA levels in the tissues. Differentiation was determined by measuring involucrin, keratinocyte transglutaminase, as well as cytokeratins 10, 16, and 17. Proliferation markers such as PCNA and c-myc were also determined. RESULTS: The transcription pattern of HPV in perianal condylomas, which preferentially expressed the early (E7) gene, was different from that of penile condylomas, which primarily expressed the late (L1) gene. This transcription pattern is in good correlation with the keratinisation and differentiation patterns of the two epithelia: perianal biopsies preferentially expressed K16 and K17 while penile warts mainly expressed K10, markers of parakeratotic and orthokeratotic epithelia, respectively. Perianal biopsies also showed a higher degree of proliferation (PCNA and c-myc). Interestingly, transcription of HIV-tat was also higher in perianal than in penile biopsies. A high degree of local immunodeficiency was observed in perianal biopsies--that is, levels of CD4, CD16, and CD1a mRNAs were significantly lower. A negative correlation between CD1a (Langerhans cells) levels and HPV E7 levels was established. HPV E7 levels positively correlated with HIV-tat levels. Perianal tissues demonstrated more CD1a depression and tat associated HPV upregulation. CONCLUSION: HIV influences the expression of HPV genes resulting in local immunosuppression that might lead to an inappropriate immune surveillance of viral infection. Also, tissue type is an important factor in controlling viral transcription in a differentiation dependent manner. These findings may explain the higher rate of dysplasia and neoplasia in the perianal area.  (+info)

HIV seropositivity is a term used to describe a positive result on an HIV antibody test. This means that the individual has developed antibodies against the Human Immunodeficiency Virus (HIV), indicating that they have been infected with the virus. However, it's important to note that this does not necessarily mean that the person has AIDS, as there can be a long period between HIV infection and the development of AIDS.

HIV seroprevalence refers to the proportion or percentage of a population that has antibodies against the Human Immunodeficiency Virus (HIV) in their blood, indicating current or previous HIV infection. It is often determined through serological testing methods that detect the presence of HIV antibodies in blood samples. The data from HIV seroprevalence studies are essential for understanding the spread and distribution of HIV within a specific population or geographic area, helping to inform public health policies and interventions aimed at controlling and preventing HIV transmission.

HIV (Human Immunodeficiency Virus) infection is a viral illness that progressively attacks and weakens the immune system, making individuals more susceptible to other infections and diseases. The virus primarily infects CD4+ T cells, a type of white blood cell essential for fighting off infections. Over time, as the number of these immune cells declines, the body becomes increasingly vulnerable to opportunistic infections and cancers.

HIV infection has three stages:

1. Acute HIV infection: This is the initial stage that occurs within 2-4 weeks after exposure to the virus. During this period, individuals may experience flu-like symptoms such as fever, fatigue, rash, swollen glands, and muscle aches. The virus replicates rapidly, and the viral load in the body is very high.
2. Chronic HIV infection (Clinical latency): This stage follows the acute infection and can last several years if left untreated. Although individuals may not show any symptoms during this phase, the virus continues to replicate at low levels, and the immune system gradually weakens. The viral load remains relatively stable, but the number of CD4+ T cells declines over time.
3. AIDS (Acquired Immunodeficiency Syndrome): This is the most advanced stage of HIV infection, characterized by a severely damaged immune system and numerous opportunistic infections or cancers. At this stage, the CD4+ T cell count drops below 200 cells/mm3 of blood.

It's important to note that with proper antiretroviral therapy (ART), individuals with HIV infection can effectively manage the virus, maintain a healthy immune system, and significantly reduce the risk of transmission to others. Early diagnosis and treatment are crucial for improving long-term health outcomes and reducing the spread of HIV.

Substance abuse, intravenous, refers to the harmful or hazardous use of psychoactive substances that are introduced directly into the bloodstream through injection, for non-medical purposes. This behavior can lead to a range of short- and long-term health consequences, including addiction, dependence, and an increased risk of infectious diseases such as HIV and hepatitis C. Intravenous substance abuse often involves drugs such as heroin, cocaine, and amphetamines, and is characterized by the repeated injection of these substances using needles and syringes. The practice can also have serious social consequences, including disrupted family relationships, lost productivity, and criminal behavior.

Sexual behavior refers to any physical or emotional interaction that has the potential to lead to sexual arousal and/or satisfaction. This can include a wide range of activities, such as kissing, touching, fondling, oral sex, vaginal sex, anal sex, and masturbation. It can also involve the use of sexual aids, such as vibrators or pornography.

Sexual behavior is influenced by a variety of factors, including biological, psychological, social, and cultural influences. It is an important aspect of human development and relationships, and it is essential to healthy sexual functioning and satisfaction. However, sexual behavior can also be associated with risks, such as sexually transmitted infections (STIs) and unintended pregnancies, and it is important for individuals to engage in safe and responsible sexual practices.

It's important to note that sexual behavior can vary widely among individuals and cultures, and what may be considered normal or acceptable in one culture or context may not be in another. It's also important to recognize that all individuals have the right to make informed decisions about their own sexual behavior and to have their sexual rights and autonomy respected.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

Seroepidemiologic studies are a type of epidemiological study that measures the presence and levels of antibodies in a population's blood serum to investigate the prevalence, distribution, and transmission of infectious diseases. These studies help to identify patterns of infection and immunity within a population, which can inform public health policies and interventions.

Seroepidemiologic studies typically involve collecting blood samples from a representative sample of individuals in a population and testing them for the presence of antibodies against specific pathogens. The results are then analyzed to estimate the prevalence of infection and immunity within the population, as well as any factors associated with increased or decreased risk of infection.

These studies can provide valuable insights into the spread of infectious diseases, including emerging and re-emerging infections, and help to monitor the effectiveness of vaccination programs. Additionally, seroepidemiologic studies can also be used to investigate the transmission dynamics of infectious agents, such as identifying sources of infection or tracking the spread of antibiotic resistance.

Antibodies, viral are proteins produced by the immune system in response to an infection with a virus. These antibodies are capable of recognizing and binding to specific antigens on the surface of the virus, which helps to neutralize or destroy the virus and prevent its replication. Once produced, these antibodies can provide immunity against future infections with the same virus.

Viral antibodies are typically composed of four polypeptide chains - two heavy chains and two light chains - that are held together by disulfide bonds. The binding site for the antigen is located at the tip of the Y-shaped structure, formed by the variable regions of the heavy and light chains.

There are five classes of antibodies in humans: IgA, IgD, IgE, IgG, and IgM. Each class has a different function and is distributed differently throughout the body. For example, IgG is the most common type of antibody found in the bloodstream and provides long-term immunity against viruses, while IgA is found primarily in mucous membranes and helps to protect against respiratory and gastrointestinal infections.

In addition to their role in the immune response, viral antibodies can also be used as diagnostic tools to detect the presence of a specific virus in a patient's blood or other bodily fluids.

Bacterial antibodies are a type of antibodies produced by the immune system in response to an infection caused by bacteria. These antibodies are proteins that recognize and bind to specific antigens on the surface of the bacterial cells, marking them for destruction by other immune cells. Bacterial antibodies can be classified into several types based on their structure and function, including IgG, IgM, IgA, and IgE. They play a crucial role in the body's defense against bacterial infections and provide immunity to future infections with the same bacteria.

'Chlamydophila pneumoniae' is a type of bacteria that can cause respiratory infections in humans. It is the causative agent of a form of pneumonia known as "atypical pneumonia," which is characterized by milder symptoms and a slower onset than other types of pneumonia.

The bacteria are transmitted through respiratory droplets, such as those produced when an infected person coughs or sneezes. 'Chlamydophila pneumoniae' infections can occur throughout the year, but they are more common in the fall and winter months.

Symptoms of a 'Chlamydophila pneumoniae' infection may include cough, chest pain, fever, fatigue, and difficulty breathing. The infection can also cause other respiratory symptoms, such as sore throat, headache, and muscle aches. In some cases, the infection may spread to other parts of the body, causing complications such as ear infections or inflammation of the heart or brain.

Diagnosis of 'Chlamydophila pneumoniae' infection typically involves testing a sample of respiratory secretions, such as sputum or nasal swabs, for the presence of the bacteria. Treatment usually involves antibiotics, such as azithromycin or doxycycline, which are effective against 'Chlamydophila pneumoniae'.

It's important to note that while 'Chlamydophila pneumoniae' infections can cause serious respiratory illness, they are generally not as severe as other types of bacterial pneumonia. However, if left untreated, the infection can lead to complications and worsening symptoms.

Chlamydophila infections are caused by bacteria belonging to the genus Chlamydophila, which includes several species that can infect humans and animals. The two most common species that cause infections in humans are Chlamydophila pneumoniae and Chlamydophila trachomatis.

Chlamydophila pneumoniae is responsible for respiratory infections, including pneumonia, bronchitis, and sinusitis. It is usually spread through respiratory droplets and can cause both mild and severe illnesses.

Chlamydophila trachomatis causes a wide range of infections, depending on the serovar (strain) involved. The most common types of Chlamydia trachomatis infections include:

1. Nongonococcal urethritis and cervicitis: These are sexually transmitted infections that can cause inflammation of the urethra and cervix, respectively. Symptoms may include discharge, pain during urination, and painful intercourse.
2. Lymphogranuloma venereum (LGV): This is a sexually transmitted infection that primarily affects the lymphatic system. It can cause symptoms such as genital ulcers, swollen lymph nodes, and rectal pain and discharge.
3. Trachoma: This is an eye infection caused by a specific serovar of Chlamydia trachomatis. It is the leading infectious cause of blindness worldwide and primarily affects populations in developing countries with poor sanitation.
4. Inclusion conjunctivitis: This is an eye infection that mainly affects newborns, causing inflammation of the conjunctiva (the membrane lining the eyelids). It can be transmitted from mother to child during childbirth and may lead to vision problems if left untreated.

Diagnosis of Chlamydophila infections typically involves laboratory tests such as nucleic acid amplification tests (NAATs) or culture methods. Treatment usually consists of antibiotics, such as azithromycin or doxycycline, and may involve additional measures depending on the site and severity of infection. Prevention strategies include practicing safe sex, maintaining good hygiene, and receiving appropriate vaccinations for at-risk populations.

Immunoglobulin G (IgG) is a type of antibody, which is a protective protein produced by the immune system in response to foreign substances like bacteria or viruses. IgG is the most abundant type of antibody in human blood, making up about 75-80% of all antibodies. It is found in all body fluids and plays a crucial role in fighting infections caused by bacteria, viruses, and toxins.

IgG has several important functions:

1. Neutralization: IgG can bind to the surface of bacteria or viruses, preventing them from attaching to and infecting human cells.
2. Opsonization: IgG coats the surface of pathogens, making them more recognizable and easier for immune cells like neutrophils and macrophages to phagocytose (engulf and destroy) them.
3. Complement activation: IgG can activate the complement system, a group of proteins that work together to help eliminate pathogens from the body. Activation of the complement system leads to the formation of the membrane attack complex, which creates holes in the cell membranes of bacteria, leading to their lysis (destruction).
4. Antibody-dependent cellular cytotoxicity (ADCC): IgG can bind to immune cells like natural killer (NK) cells and trigger them to release substances that cause target cells (such as virus-infected or cancerous cells) to undergo apoptosis (programmed cell death).
5. Immune complex formation: IgG can form immune complexes with antigens, which can then be removed from the body through various mechanisms, such as phagocytosis by immune cells or excretion in urine.

IgG is a critical component of adaptive immunity and provides long-lasting protection against reinfection with many pathogens. It has four subclasses (IgG1, IgG2, IgG3, and IgG4) that differ in their structure, function, and distribution in the body.

Serologic tests are laboratory tests that detect the presence or absence of antibodies or antigens in a patient's serum (the clear liquid that separates from clotted blood). These tests are commonly used to diagnose infectious diseases, as well as autoimmune disorders and other medical conditions.

In serologic testing for infectious diseases, a sample of the patient's blood is collected and allowed to clot. The serum is then separated from the clot and tested for the presence of antibodies that the body has produced in response to an infection. The test may be used to identify the specific type of infection or to determine whether the infection is active or has resolved.

Serologic tests can also be used to diagnose autoimmune disorders, such as rheumatoid arthritis and lupus, by detecting the presence of antibodies that are directed against the body's own tissues. These tests can help doctors confirm a diagnosis and monitor the progression of the disease.

It is important to note that serologic tests are not always 100% accurate and may produce false positive or false negative results. Therefore, they should be interpreted in conjunction with other clinical findings and laboratory test results.

An Enzyme-Linked Immunosorbent Assay (ELISA) is a type of analytical biochemistry assay used to detect and quantify the presence of a substance, typically a protein or peptide, in a liquid sample. It takes its name from the enzyme-linked antibodies used in the assay.

In an ELISA, the sample is added to a well containing a surface that has been treated to capture the target substance. If the target substance is present in the sample, it will bind to the surface. Next, an enzyme-linked antibody specific to the target substance is added. This antibody will bind to the captured target substance if it is present. After washing away any unbound material, a substrate for the enzyme is added. If the enzyme is present due to its linkage to the antibody, it will catalyze a reaction that produces a detectable signal, such as a color change or fluorescence. The intensity of this signal is proportional to the amount of target substance present in the sample, allowing for quantification.

ELISAs are widely used in research and clinical settings to detect and measure various substances, including hormones, viruses, and bacteria. They offer high sensitivity, specificity, and reproducibility, making them a reliable choice for many applications.

HIV seronegativity is a term used to describe a person who has tested negative for HIV (Human Immunodeficiency Virus) antibodies in their blood. This means that the individual does not show evidence of current or past infection with HIV, which can cause AIDS (Acquired Immune Deficiency Syndrome). However, it's important to note that there is a window period after initial infection during which a person may test negative for HIV antibodies, even though they are indeed infected. This window period typically lasts between 2-6 weeks but can extend up to 3 months in some cases. Therefore, if someone believes they have been exposed to HIV, they should consider getting tested again after this window period has passed.

Prevalence, in medical terms, refers to the total number of people in a given population who have a particular disease or condition at a specific point in time, or over a specified period. It is typically expressed as a percentage or a ratio of the number of cases to the size of the population. Prevalence differs from incidence, which measures the number of new cases that develop during a certain period.

Helicobacter pylori (H. pylori) is a gram-negative, microaerophilic bacterium that colonizes the stomach of approximately 50% of the global population. It is closely associated with gastritis and peptic ulcer disease, and is implicated in the pathogenesis of gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma. H. pylori infection is usually acquired in childhood and can persist for life if not treated. The bacterium's spiral shape and flagella allow it to penetrate the mucus layer and adhere to the gastric epithelium, where it releases virulence factors that cause inflammation and tissue damage. Diagnosis of H. pylori infection can be made through various tests, including urea breath test, stool antigen test, or histological examination of a gastric biopsy. Treatment typically involves a combination of antibiotics and proton pump inhibitors to eradicate the bacteria and promote healing of the stomach lining.

Helicobacter infections are caused by the bacterium Helicobacter pylori (H. pylori), which colonizes the stomach lining and is associated with various gastrointestinal diseases. The infection can lead to chronic active gastritis, peptic ulcers, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, and gastric cancer.

The spiral-shaped H. pylori bacteria are able to survive in the harsh acidic environment of the stomach by producing urease, an enzyme that neutralizes gastric acid in their immediate vicinity. This allows them to adhere to and colonize the epithelial lining of the stomach, where they can cause inflammation (gastritis) and disrupt the normal functioning of the stomach.

Transmission of H. pylori typically occurs through oral-oral or fecal-oral routes, and infection is more common in developing countries and in populations with lower socioeconomic status. The diagnosis of Helicobacter infections can be confirmed through various tests, including urea breath tests, stool antigen tests, or gastric biopsy with histology and culture. Treatment usually involves a combination of antibiotics and proton pump inhibitors to eradicate the bacteria and reduce stomach acidity.

Toxocariasis is a parasitic infection caused by the roundworms Toxocara canis or Toxocara cati, which are found in the intestines of dogs and cats, respectively. Humans become infected through the accidental ingestion of infective eggs from contaminated soil, water, or food. The larvae hatch in the small intestine and migrate to various tissues, including the liver, lungs, eyes, and central nervous system, where they can cause inflammation and damage.

The severity of the infection depends on the number of larvae that have infected the body and the organs involved. Most infections are asymptomatic or mild, causing symptoms such as fever, cough, rash, or abdominal discomfort. However, in severe cases, toxocariasis can lead to serious complications, including blindness (ocular larva migrans) or neurological damage (visceral larva migrans).

Preventive measures include good hygiene practices, such as washing hands after handling soil or pets, and avoiding contact with dog or cat feces. Regular deworming of pets can also help reduce the risk of transmission.

Antibodies, protozoan, refer to the immune system's response to an infection caused by a protozoan organism. Protozoa are single-celled microorganisms that can cause various diseases in humans, such as malaria, giardiasis, and toxoplasmosis.

When the body is infected with a protozoan, the immune system responds by producing specific proteins called antibodies. Antibodies are produced by a type of white blood cell called a B-cell, and they recognize and bind to specific antigens on the surface of the protozoan organism.

There are five main types of antibodies: IgA, IgD, IgE, IgG, and IgM. Each type of antibody has a different role in the immune response. For example, IgG is the most common type of antibody and provides long-term immunity to previously encountered pathogens. IgM is the first antibody produced in response to an infection and is important for activating the complement system, which helps to destroy the protozoan organism.

Overall, the production of antibodies against protozoan organisms is a critical part of the immune response and helps to protect the body from further infection.

Cytomegalovirus (CMV) infections are caused by the human herpesvirus 5 (HHV-5), a type of herpesvirus. The infection can affect people of all ages, but it is more common in individuals with weakened immune systems, such as those with HIV/AIDS or who have undergone organ transplantation.

CMV can be spread through close contact with an infected person's saliva, urine, blood, tears, semen, or breast milk. It can also be spread through sexual contact or by sharing contaminated objects, such as toys, eating utensils, or drinking glasses. Once a person is infected with CMV, the virus remains in their body for life and can reactivate later, causing symptoms to recur.

Most people who are infected with CMV do not experience any symptoms, but some may develop a mononucleosis-like illness, characterized by fever, fatigue, swollen glands, and sore throat. In people with weakened immune systems, CMV infections can cause more severe symptoms, including pneumonia, gastrointestinal disease, retinitis, and encephalitis.

Congenital CMV infection occurs when a pregnant woman passes the virus to her fetus through the placenta. This can lead to serious complications, such as hearing loss, vision loss, developmental delays, and mental disability.

Diagnosis of CMV infections is typically made through blood tests or by detecting the virus in bodily fluids, such as urine or saliva. Treatment depends on the severity of the infection and the patient's overall health. Antiviral medications may be prescribed to help manage symptoms and prevent complications.

Toxoplasmosis is a disease caused by the parasitic protozoan Toxoplasma gondii. It can infect humans, birds, and most warm-blooded animals, including marine mammals. In humans, it is usually contracted through eating undercooked, contaminated meat or ingesting oocysts (a form of the parasite) from cat feces, often through contact with litter boxes or gardening in soil that has been contaminated with cat feces.

The infection can also be passed to the fetus if a woman becomes infected during or just before pregnancy. Most healthy individuals who become infected with Toxoplasma gondii experience few symptoms and are not aware they have the disease. However, for those with weakened immune systems, such as people with HIV/AIDS, organ transplant recipients, and pregnant women, toxoplasmosis can cause severe complications, including damage to the brain, eyes, and other organs.

Symptoms of toxoplasmosis in individuals with weakened immune systems may include swollen lymph nodes, fever, fatigue, muscle aches, and headache. In pregnant women, infection can lead to miscarriage, stillbirth, or severe developmental problems in the baby. Treatment typically involves antiparasitic medications such as pyrimethamine and sulfadiazine.

Acquired Immunodeficiency Syndrome (AIDS) is a chronic, life-threatening condition caused by the Human Immunodeficiency Virus (HIV). AIDS is the most advanced stage of HIV infection, characterized by the significant weakening of the immune system, making the person more susceptible to various opportunistic infections and cancers.

The medical definition of AIDS includes specific criteria based on CD4+ T-cell count or the presence of certain opportunistic infections and diseases. According to the Centers for Disease Control and Prevention (CDC), a person with HIV is diagnosed with AIDS when:

1. The CD4+ T-cell count falls below 200 cells per cubic millimeter of blood (mm3) - a normal range is typically between 500 and 1,600 cells/mm3.
2. They develop one or more opportunistic infections or cancers that are indicative of advanced HIV disease, regardless of their CD4+ T-cell count.

Some examples of these opportunistic infections and cancers include:

* Pneumocystis pneumonia (PCP)
* Candidiasis (thrush) affecting the esophagus, trachea, or lungs
* Cryptococcal meningitis
* Toxoplasmosis of the brain
* Cytomegalovirus disease
* Kaposi's sarcoma
* Non-Hodgkin's lymphoma
* Invasive cervical cancer

It is important to note that with appropriate antiretroviral therapy (ART), people living with HIV can maintain their CD4+ T-cell counts, suppress viral replication, and prevent the progression to AIDS. Early diagnosis and consistent treatment are crucial for managing HIV and improving life expectancy and quality of life.

A cross-sectional study is a type of observational research design that examines the relationship between variables at one point in time. It provides a snapshot or a "cross-section" of the population at a particular moment, allowing researchers to estimate the prevalence of a disease or condition and identify potential risk factors or associations.

In a cross-sectional study, data is collected from a sample of participants at a single time point, and the variables of interest are measured simultaneously. This design can be used to investigate the association between exposure and outcome, but it cannot establish causality because it does not follow changes over time.

Cross-sectional studies can be conducted using various data collection methods, such as surveys, interviews, or medical examinations. They are often used in epidemiology to estimate the prevalence of a disease or condition in a population and to identify potential risk factors that may contribute to its development. However, because cross-sectional studies only provide a snapshot of the population at one point in time, they cannot account for changes over time or determine whether exposure preceded the outcome.

Therefore, while cross-sectional studies can be useful for generating hypotheses and identifying potential associations between variables, further research using other study designs, such as cohort or case-control studies, is necessary to establish causality and confirm any findings.

Toxocara is a type of parasitic roundworm that belongs to the genus Toxocara. The two most common species that infect humans are Toxocara canis and Toxocara cati, which are primarily found in dogs and cats, respectively.

Humans can become infected with Toxocara through accidental ingestion of contaminated soil or sand that contains the eggs of the parasite. This can occur when people come into contact with infected animal feces and then touch their mouths without properly washing their hands. Children are particularly at risk of infection due to their frequent hand-to-mouth behaviors and tendency to play in environments where the eggs may be present.

In humans, Toxocara infection can cause a range of symptoms known as toxocariasis. The most common form is visceral larva migrans (VLM), which occurs when the parasite's larvae migrate through various organs in the body, causing inflammation and damage. Symptoms of VLM may include fever, fatigue, coughing, wheezing, abdominal pain, and liver enlargement.

Another form of toxocariasis is ocular larva migrans (OLM), which occurs when the parasite's larvae migrate to the eye, causing inflammation and potentially leading to vision loss. Symptoms of OLM may include eye pain, redness, blurred vision, and light sensitivity.

Preventive measures for Toxocara infection include washing hands thoroughly after handling animals or coming into contact with soil, covering sandboxes when not in use, and cooking meat thoroughly before eating. Treatment for toxocariasis typically involves anti-parasitic medications such as albendazole or mebendazole, which can help kill the parasite's larvae and reduce symptoms.

Medical Definition of "Herpesvirus 2, Human" (also known as Human Herpesvirus 2 or HHV-2):

Herpesvirus 2, Human is a double-stranded DNA virus that belongs to the Herpesviridae family. It is one of the eight herpesviruses known to infect humans. HHV-2 is the primary cause of genital herpes, a sexually transmitted infection (STI) that affects the mucosal surfaces and skin around the genitals, rectum, or mouth.

The virus is typically transmitted through sexual contact with an infected person, and it can also be spread from mother to child during childbirth if the mother has active genital lesions. After initial infection, HHV-2 establishes latency in the sacral ganglia (a collection of nerve cells at the base of the spine) and may reactivate periodically, leading to recurrent outbreaks of genital herpes.

During both primary and recurrent infections, HHV-2 can cause painful blisters or ulcers on the skin or mucous membranes, as well as flu-like symptoms such as fever, swollen lymph nodes, and body aches. While there is no cure for genital herpes, antiviral medications can help manage symptoms, reduce outbreak frequency, and lower the risk of transmission to sexual partners.

It's important to note that HHV-2 infection can sometimes be asymptomatic or cause mild symptoms that go unnoticed, making it difficult to determine the exact prevalence of the virus in the population. According to the World Health Organization (WHO), an estimated 491 million people worldwide aged 15 years and older have HSV-2 infection, with a higher prevalence in women than men.

AIDS serodiagnosis refers to the detection and confirmation of HIV (Human Immunodeficiency Virus) infection through the identification of antibodies produced by the immune system in response to the virus. These antibodies are typically detected in blood samples using various testing methods, such as ELISA (Enzyme-Linked Immunosorbent Assay) and Western blot. A positive result in both tests indicates a high probability of HIV infection and progression to AIDS (Acquired Immune Deficiency Syndrome), provided the individual has not been recently infected, as it may take several weeks for the antibodies to develop and become detectable. Regular testing and early diagnosis are crucial for timely medical intervention, treatment, and prevention of further transmission.

HIV-1 (Human Immunodeficiency Virus type 1) is a species of the retrovirus genus that causes acquired immunodeficiency syndrome (AIDS). It is primarily transmitted through sexual contact, exposure to infected blood or blood products, and from mother to child during pregnancy, childbirth, or breastfeeding. HIV-1 infects vital cells in the human immune system, such as CD4+ T cells, macrophages, and dendritic cells, leading to a decline in their numbers and weakening of the immune response over time. This results in the individual becoming susceptible to various opportunistic infections and cancers that ultimately cause death if left untreated. HIV-1 is the most prevalent form of HIV worldwide and has been identified as the causative agent of the global AIDS pandemic.

A blood donor is a person who voluntarily gives their own blood or blood components to be used for the benefit of another person in need. The blood donation process involves collecting the donor's blood, testing it for infectious diseases, and then storing it until it is needed by a patient. There are several types of blood donations, including:

1. Whole blood donation: This is the most common type of blood donation, where a donor gives one unit (about 450-500 milliliters) of whole blood. The blood is then separated into its components (red cells, plasma, and platelets) for transfusion to patients with different needs.
2. Double red cell donation: In this type of donation, the donor's blood is collected using a special machine that separates two units of red cells from the whole blood. The remaining plasma and platelets are returned to the donor during the donation process. This type of donation can be done every 112 days.
3. Platelet donation: A donor's blood is collected using a special machine that separates platelets from the whole blood. The red cells and plasma are then returned to the donor during the donation process. This type of donation can be done every seven days, up to 24 times a year.
4. Plasma donation: A donor's blood is collected using a special machine that separates plasma from the whole blood. The red cells and platelets are then returned to the donor during the donation process. This type of donation can be done every 28 days, up to 13 times a year.

Blood donors must meet certain eligibility criteria, such as being in good health, aged between 18 and 65 (in some countries, the upper age limit may vary), and weighing over 50 kg (110 lbs). Donors are also required to answer medical questionnaires and undergo a mini-physical examination before each donation. The frequency of blood donations varies depending on the type of donation and the donor's health status.

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). It's primarily spread through contact with contaminated blood, often through sharing needles or other equipment to inject drugs. For some people, hepatitis C is a short-term illness but for most — about 75-85% — it becomes a long-term, chronic infection that can lead to serious health problems like liver damage, liver failure, and even liver cancer. The virus can infect and inflame the liver, causing symptoms like jaundice (yellowing of the skin and eyes), abdominal pain, fatigue, and dark urine. Many people with hepatitis C don't have any symptoms, so they might not know they have the infection until they experience complications. There are effective treatments available for hepatitis C, including antiviral medications that can cure the infection in most people. Regular testing is important to diagnose and treat hepatitis C early, before it causes serious health problems.

Neospora is a genus of intracellular parasites that belong to the phylum Apicomplexa. The most common species that affects animals is Neospora caninum, which is known to cause serious disease in cattle and dogs. It can also infect other warm-blooded animals, including sheep, goats, horses, and deer.

Neosporosis, the infection caused by Neospora, primarily affects the nervous system and muscles of the host animal. In cattle, it is a major cause of abortion, stillbirths, and neurological disorders. The parasite can be transmitted through the placenta from an infected mother to her offspring (congenital transmission), or through the ingestion of contaminated feed or water (horizontal transmission).

Neospora is a significant economic concern for the livestock industry, particularly in dairy and beef cattle operations. There is no effective vaccine or treatment available for neosporosis in animals, so prevention efforts focus on identifying and isolating infected animals to reduce the spread of the parasite.

A case-control study is an observational research design used to identify risk factors or causes of a disease or health outcome. In this type of study, individuals with the disease or condition (cases) are compared with similar individuals who do not have the disease or condition (controls). The exposure history or other characteristics of interest are then compared between the two groups to determine if there is an association between the exposure and the disease.

Case-control studies are often used when it is not feasible or ethical to conduct a randomized controlled trial, as they can provide valuable insights into potential causes of diseases or health outcomes in a relatively short period of time and at a lower cost than other study designs. However, because case-control studies rely on retrospective data collection, they are subject to biases such as recall bias and selection bias, which can affect the validity of the results. Therefore, it is important to carefully design and conduct case-control studies to minimize these potential sources of bias.

Papillomavirus infections are a group of diseases caused by various types of human papillomaviruses (HPVs). These viruses infect the skin and mucous membranes, and can cause benign growths such as warts or papillomas, as well as malignant growths like cervical cancer.

There are more than 100 different types of HPVs, and they can be classified into low-risk and high-risk types based on their potential to cause cancer. Low-risk HPV types, such as HPV-6 and HPV-11, commonly cause benign genital warts and respiratory papillomas. High-risk HPV types, such as HPV-16 and HPV-18, are associated with an increased risk of developing cancer, including cervical, anal, penile, vulvar, and oropharyngeal cancers.

HPV infections are typically transmitted through sexual contact, and most sexually active individuals will acquire at least one HPV infection during their lifetime. In many cases, the immune system is able to clear the virus without any symptoms or long-term consequences. However, persistent high-risk HPV infections can lead to the development of cancer over time.

Prevention measures for HPV infections include vaccination against high-risk HPV types, safe sex practices, and regular screening for cervical cancer in women. The HPV vaccine is recommended for both boys and girls aged 11-12 years old, and can also be given to older individuals up to age 45 who have not previously been vaccinated or who have not completed the full series of shots.

A rural population refers to people who live in areas that are outside of urban areas, typically defined as having fewer than 2,000 residents and lacking certain infrastructure and services such as running water, sewage systems, and paved roads. Rural populations often have less access to healthcare services, education, and economic opportunities compared to their urban counterparts. This population group can face unique health challenges, including higher rates of poverty, limited access to specialized medical care, and a greater exposure to environmental hazards such as agricultural chemicals and industrial pollutants.

Syphilis is a sexually transmitted infection (STI) caused by the bacterium Treponema pallidum. It progresses in several stages if left untreated, with symptoms varying in each stage. The primary stage involves the appearance of a single, painless sore or multiple sores at the site where the bacteria entered the body, often on the genitals or around the mouth. During the secondary stage, individuals may experience rashes, fever, swollen lymph nodes, and other flu-like symptoms. In later stages, syphilis can lead to severe complications affecting the heart, brain, and other organs, known as tertiary syphilis. Neurosyphilis is a form of tertiary syphilis that affects the nervous system, causing various neurological problems. Congenital syphilis occurs when a pregnant woman with syphilis transmits the infection to her unborn child, which can result in serious birth defects and health issues for the infant. Early detection and appropriate antibiotic treatment can cure syphilis and prevent further complications.

Herpes genitalis is a sexually transmitted infection caused by the herpes simplex virus (HSV), specifically HSV-2, and occasionally HSV-1. It primarily affects the genital area, but can also involve the anal region, thighs, and buttocks. The infection presents as painful fluid-filled blisters or lesions that may be accompanied by symptoms such as itching, tingling, or burning sensations in the affected area. After the initial outbreak, the virus remains dormant in the body and can reactivate periodically, causing recurrent episodes of genital herpes. It's important to note that while there is no cure for herpes genitalis, antiviral medications can help manage symptoms and reduce transmission risks.

Cytomegalovirus (CMV) is a type of herpesvirus that can cause infection in humans. It is characterized by the enlargement of infected cells (cytomegaly) and is typically transmitted through close contact with an infected person, such as through saliva, urine, breast milk, or sexual contact.

CMV infection can also be acquired through organ transplantation, blood transfusions, or during pregnancy from mother to fetus. While many people infected with CMV experience no symptoms, it can cause serious complications in individuals with weakened immune systems, such as those undergoing cancer treatment or those who have HIV/AIDS.

In newborns, congenital CMV infection can lead to hearing loss, vision problems, and developmental delays. Pregnant women who become infected with CMV for the first time during pregnancy are at higher risk of transmitting the virus to their unborn child. There is no cure for CMV, but antiviral medications can help manage symptoms and reduce the risk of complications in severe cases.

"Toxoplasma" is a genus of protozoan parasites, and the most well-known species is "Toxoplasma gondii." This particular species is capable of infecting virtually all warm-blooded animals, including humans. It's known for its complex life cycle that involves felines (cats) as the definitive host.

Infection in humans, called toxoplasmosis, often occurs through ingestion of contaminated food or water, or through contact with cat feces that contain T. gondii oocysts. While many people infected with Toxoplasma show no symptoms, it can cause serious health problems in immunocompromised individuals and developing fetuses if a woman becomes infected during pregnancy.

It's important to note that while I strive to provide accurate information, this definition should not be used for self-diagnosis or treatment. Always consult with a healthcare professional for medical advice.

Immunoglobulin A (IgA) is a type of antibody that plays a crucial role in the immune function of the human body. It is primarily found in external secretions, such as saliva, tears, breast milk, and sweat, as well as in mucous membranes lining the respiratory and gastrointestinal tracts. IgA exists in two forms: a monomeric form found in serum and a polymeric form found in secretions.

The primary function of IgA is to provide immune protection at mucosal surfaces, which are exposed to various environmental antigens, such as bacteria, viruses, parasites, and allergens. By doing so, it helps prevent the entry and colonization of pathogens into the body, reducing the risk of infections and inflammation.

IgA functions by binding to antigens present on the surface of pathogens or allergens, forming immune complexes that can neutralize their activity. These complexes are then transported across the epithelial cells lining mucosal surfaces and released into the lumen, where they prevent the adherence and invasion of pathogens.

In summary, Immunoglobulin A (IgA) is a vital antibody that provides immune defense at mucosal surfaces by neutralizing and preventing the entry of harmful antigens into the body.

I apologize, but "Brazil" is not a medical term or condition. It is the largest country in both South America and Latin America by land area and population. If you have any questions related to medical terminology or health concerns, please provide more information and I will do my best to help.

Medical definitions are often avoided in favor of more objective language when discussing personal characteristics or identities, such as sexual orientation. This is because sexual orientation is not considered a medical condition or disorder, but rather a natural part of human diversity. The American Psychological Association defines sexual orientation as "an enduring emotional, romantic, sexual, or affectional attraction to another person." It can be distinguished into different categories, including heterosexuality (attraction to individuals of the other gender), bisexuality (attraction to individuals of either gender), and homosexuality (attraction to individuals of the same gender).

It's important to note that a person's sexual orientation is not considered a choice or something that can be changed through willpower or therapy. It is a deeply ingrained aspect of a person's identity, and it is protected under laws and regulations in many countries as a fundamental human right.

Krueger LE, Wood RW, Diehr PH, Maxwell CL (August 1990). "Poverty and HIV seropositivity: the poor are more likely to be ... HIV in pregnancy is the presence of an HIV/AIDS infection in a woman while she is pregnant. There is a risk of HIV transmission ... Any positive HIV testing should be repeated as soon as possible. HIV cannot be excluded as a diagnosis in an HIV-exposed, non- ... The WHO's 2010 HIV and Infant Feeding Recommendations intend to increase the rate of HIV-survival and reduce non-HIV related ...
The term serostatus is commonly used in HIV/AIDS prevention efforts. In the late 20th and early 21st centuries, social advocacy ... The presence of detectable levels of a specific marker within the serum is considered seropositivity, while the absence of such ... July 2001). "The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals". American ... Articles with short description, Short description is different from Wikidata, Serology, HIV/AIDS). ...
The development of a nucleic acid test for the HIV-1 RNA has dramatically lowered the rate of donor blood seropositivity to ... As transmittance of HIV does not necessarily mean HIV infection, the latter could still occur at an even lower rate. The ... Since the advent of HIV testing of donor blood in the mid/later 1980s, ex. 1985's ELISA, the transmission of HIV during ... As with HIV, this low rate has been attributed to the ability to screen for both antibodies as well as viral RNA nucleic acid ...
HIV) Seropositivity among Uninfected HIV Vaccine Recipients". The Journal of Infectious Diseases. University of Chicago Press. ... "Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients". Journal of the American Medical ... A person who is HIV negative, and has received an HIV vaccine, and who then tests as positive in an HIV test is said to be ... may face discrimination because of HIV infection. In 1987 in America the first HIV vaccine was tested. HIV vaccines have been ...
HIV seropositivity, drug addiction, smoking cessation, cardiovascular risks, social medicine). The CHU of Toulouse is a partner ...
In the mid-1980s the association with A1-B8-DR3 and HIV progression appeared shortly after the discover of the virus. A1-B8 ... associated with more rapid progression to seropositivity, and was strongly associated with a rapid decline in T4 cells and ... May 1988). "HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease". Lancet. 1 (8596): 1185-8. doi:10.1016/S0140-6736 ... April 1990). "A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection ...
... hiv enteropathy MeSH C20.673.480.500 - hiv seropositivity MeSH C20.673.480.520 - hiv wasting syndrome MeSH C20.673.483.260 - ... hiv-associated lipodystrophy syndrome MeSH C20.673.480.480 - ...
"About HIV/AIDS". www.cdc.gov. 1 June 2021. Retrieved 7 November 2021. "What is the window period for an HIV test?". i-base.info ... Even for individuals who seroconverted, seropositivity is at best only as protective as a single dose of vaccine, as opposed to ... "Window Period {". clinicalinfo.hiv.gov. Retrieved 5 November 2021. "What is the window period for HIV testing?". aidsmap.com. ... An individual may have a transmittable HIV infection before the individual becomes HIV positive due to the window period. In ...
... hiv enteropathy MeSH C02.782.815.616.400.500 - hiv seropositivity MeSH C02.782.815.616.400.520 - hiv wasting syndrome MeSH ... hiv enteropathy MeSH C02.800.801.400.500 - hiv seropositivity MeSH C02.800.801.400.520 - hiv wasting syndrome MeSH C02.825. ... hiv infections MeSH C02.782.815.616.400.040 - acquired immunodeficiency syndrome MeSH C02.782.815.616.400.048 - aids arteritis ... hiv infections MeSH C02.800.801.400.040 - acquired immunodeficiency syndrome MeSH C02.800.801.400.048 - aids arteritis, central ...
... seropositivity, being 37.5% among patients repeatedly seen in the STD clinic) and that HIV was transmitted heterosexually. He ... he published the first report to document that hemophiliacs were heavily infected with HIV and later the same year that HIV ... In 1984, he showed that in Danish gay men, HIV infection occurred via sexual contact with gay men in the US and that the ... HIV/AIDS--an epidemiological challenge". Nordisk Medicin. 108 (3): 72-75. PMID 8455974. Scholia has an author profile for Mads ...
In Thailand, the seropositivity rate exceeds 50%, while in Australia the seropositivity rate is only 5%. The disease is clearly ... Despite this, HIV infection is not a risk factor for melioidosis. Although macrophages show deregulated cytokine responses in ... HIV infection does not appear to predispose to melioidosis, although several other co-infections have been reported. Infant ... individuals with HIV infection, bacterial internalization and intracellular killing are still effective. People infected with B ...
To monitor other emerging and reemerging infectious diseases, studies have been done on diseases such as recurrent fever, HIV, ... reports on tularemia seropositivity in human high-risk groups in Kurdistan and Sistan and Baluchestan provinces and the first ...
HHV-6 upregulates the expression of the primary HIV receptor CD4, thus expanding the range of HIV susceptible cells. Several ... There are inconsistencies with the correlations between age and seropositivity: According to some reports there is a decrease ... Likewise in HIV/AIDS, HHV-6 re-activations cause disseminated infections leading to end organ disease and death. Although up to ... It has been demonstrated that HHV-6 fosters the progression of HIV-1 upon coinfection in T cells. ...
Seropositivity tests look for the presence of antibodies against T. gondii in blood, so while seropositivity guarantees one has ... Treatment is recommended for people with serious health problems, such as people with HIV whose CD4 counts are under 200 cells/ ... Combination therapy is most useful in the setting of HIV. Clindamycin Spiramycin - an antibiotic used most often for pregnant ... Pedro Zamora, reality television personality and HIV/AIDS activist, was diagnosed with toxoplasmosis as a result of his immune ...
"Researchers a step closer to making HIV vaccine". Medical News Today. April 5, 2013. Retrieved April 24, 2013. Hanabuchi, S.; ... schedule Vaccinator Vaccine Vaccine controversies Vaccine line jumping Vaccine wastage Vaccine-induced seropositivity Viral ... Equine encephalitis virus vaccine for humans Enterovirus 71 vaccine Epstein-Barr vaccine H5N1 vaccine Hepatitis C vaccine HIV ...
Stratton, Richard; Slapak, Gabrielle; Mahungu, Tabitha; Loes, Sabine Kinloch-de (2009). "Autoimmunity and HIV". Current Opinion ... Kar, Nilamadhab; Misra, Baikunthanath (2004). "Toxoplasma seropositivity and depression: a case report". BMC Psychiatry. 4: 1. ... Carbone, Antonino; Gloghini, Annunziata; Serraino, Diego; Spina, Michele (2009). "HIV-associated Hodgkin lymphoma". Current ... Opinion in HIV and AIDS. 4 (1): 3-10. doi:10.1097/COH.0b013e32831a722b. PMID 19339934. Michielsen, Peter P; Francque, Sven M; ...
High incidence of seropositivity to the virus was observed in pigs in 15 districts of Japan. An explanation was later found for ... A SeV-based vaccine development against HIV-1 has reached a phase II clinical trial. In Japan intranasal Sendai virus-based ... March 2008). "Comparison between Sendai virus and adenovirus vectors to transduce HIV-1 genes into human dendritic cells". ... Evaluation of the safety and immunogenicity of an intranasally administered replication-competent Sendai Virus-vectored HIV ...
Genital infection of HSV-2 increases the risk of acquiring HIV. HSV has been a model virus for many studies in molecular ... "Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study". PLOS ONE. ... HIV-1, adenovirus simian virus 40, vaccinia virus, reovirus, poliovirus and herpes simplex virus. When HSV particles are ... "Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis". The Lancet. ...
Toxoplasma seropositivity: even in the absence of symptomatic toxoplasmosis, toxoplasma gondii exposure has been linked to ... Lack of body fat is linked to poverty and HIV/AIDS. However, the emergence of Western and European influence, specifically with ... Kar N, Misra B (February 2004). "Toxoplasma seropositivity and depression: a case report". BMC Psychiatry. 4: 1. doi:10.1186/ ...
"The Relation of Cytotoxin-Associated Gene - A Seropositivity with Vitamin B12 Deficiency in Helicobacter pylori-Positive ... and HIV. PA may be considered as an end stage of autoimmune atrophic gastritis, a disease characterised by stomach atrophy and ...
Seropositivity for anti-Ro and anti-La is associated with greater severity and longer duration of disease, and findings of ... HIV), hepatitis delta virus (HDV) and hepatitis C virus (HCV). Some research has shown that a paucity of vitamin A and vitamin ...
HIV). In HIV infected persons, HCMV is considered an AIDS-defining infection, indicating that the T-cell count has dropped to ... Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello AE (2011). "Seropositivity to cytomegalovirus, inflammation, all- ... HCMV infection is typically unnoticed in healthy people, but can be life-threatening for the immunocompromised, such as HIV- ...
Deficiency may be caused by increased needs of the body for example in those with HIV/AIDS, and shortened red blood cell ... Ulasoglu C, Temiz HE, Sağlam ZA (2019). "The Relation of Cytotoxin-Associated Gene-A Seropositivity with Vitamin B12 Deficiency ...
We took advantage of the routine screening of migrants for HIV infection, upon arrival in Kuwait from the areas with high HIV ... Overall HIV seroprevalence (per 100,000) among the migrants was 21 (494/2328582) (95% CI: 19 -23), ranging from 11 (95% CI: 8 ... Towards the end of the study, a slight but non-significant upward trend in the proportions of HIV seropositive migrants was ... The monthly aggregates of daily number of migrant workers tested and number of HIV seropositive were used to generate the ...
... and low scores on cognitive tests would be associated with seropositivity among participants coming for testing for HIV/AIDS. ... may be associated with HIV status among people who have yet to receive their HIV test results. Impaired cognitive functioning ... HIV status data was extracted from clinical records. CMD and scoring below the educational norm on the test of verbal fluency ... Participants were recruited at the time of coming for testing for HIV/AIDS; voluntary informed consent was sought for ...
HIV-positive persons. 14/70 (20). 11-31. 400. Blood donors. 3/30 (10). 2-26. 200. ... Seropositivity for Enterocytozoon bieneusi, Czech Republic Bohumil Sak, Zuzana Kučerová, Martin Kváč. , Dana Květoňová, Michael ...
1991). Follow-up Study Of Possible HIV Seropositivity Among Abusers Of Parenteral Drugs In 1971-72. 106(4). Lange, W R et al. " ... "Follow-up Study Of Possible HIV Seropositivity Among Abusers Of Parenteral Drugs In 1971-72" 106, no. 4 (1991). Lange, W R et ... "Follow-up Study Of Possible HIV Seropositivity Among Abusers Of Parenteral Drugs In 1971-72" vol. 106, no. 4, 1991. Export RIS ... Title : Follow-up Study Of Possible HIV Seropositivity Among Abusers Of Parenteral Drugs In 1971-72 Personal Author(s) : Lange ...
HIV Seropositivity PubMed MeSh Term *Overview. Overview. subject area of * Cardiometabolic disease risk and HIV status in rural ... Selective use of primate CD4 receptors by HIV-1 Journal Article broader concept * Immunologic Deficiency Syndromes - HIV ...
HIV-1 seroconversion and its aftermath among homosexual men : studies on acquisition of HIV-1 and natural history of HIV-1 ... Bureau of HIV/AIDS and STD. Division of HIV/AIDS Surveillance.. Material type: Text; Format: print Publication details: Ottawa ... HIV seropositivity and AIDS prevention and control : report on a WHO meeting, Moscow, 14-17 March 1989. by World Health ... Regional Office for Europe , European Meeting on HIV Seropositivity and AIDS Prevention and Control (1989 : Moscow, Union of ...
HIV Infections / epidemiology * HIV Infections / prevention & control* * HIV Seronegativity* * HIV Seropositivity* * Humans ... safer conception strategies have been developed to help HIV-serodiscordant couples conceive a child without transmitting HIV to ... Estimated costs for the delivery of safer conception strategies for HIV-discordant couples in Zimbabwe: a cost analysis BMC ... 360 per couple over and above the cost of current HIV clinical practices. The cost of delivering the most commonly selected ...
Prior to a vaginal microbicide trial, 416 women were screened for antibodies to HIV-1 and herpes simplex virus … ... This study investigated the impact of prevalent and incident HSV-2 infection on the incidence of HIV-1 infection in a cohort of ... HIV Infections / prevention & control * HIV Infections / transmission * HIV Seropositivity * HIV-1* * Herpes Genitalis / ... A total of 187 HIV-1-seronegative women were followed up at monthly intervals when blood was drawn and used to detect HIV-1 and ...
HIV status was documented in 561 of 1 006 samples (55.8%), with 307 (54.7%) of these being HIV-positive. Of the HIV-positive ... Full text: Available Index: AIM (Africa) Main subject: South Africa / Thrombocytopenia / HIV Seropositivity / Anemia / ... Full text: Available Index: AIM (Africa) Main subject: South Africa / Thrombocytopenia / HIV Seropositivity / Anemia / ... The prevalence of HIV seropositivity and associated cytopenias in full blood counts processed at an academic laboratory in ...
HIV-seropositivity; and maternal age ≤ 25 years (risk for peripheral and placental blood parasitemia only). Maternal anemia ( ... and HIV infection) are important risk factors for malaria in pregnant women, the use of an ineffective intervention (CQ in a ... HIV) (persistent infections only); and no use of antimalarial prophylaxis before enrollment (breakthrough infections only). At ... Authors addresses: Richard W. Steketee, Epidemiology Branch, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, ...
Krueger LE, Wood RW, Diehr PH, Maxwell CL (August 1990). "Poverty and HIV seropositivity: the poor are more likely to be ... HIV in pregnancy is the presence of an HIV/AIDS infection in a woman while she is pregnant. There is a risk of HIV transmission ... Any positive HIV testing should be repeated as soon as possible. HIV cannot be excluded as a diagnosis in an HIV-exposed, non- ... The WHOs 2010 HIV and Infant Feeding Recommendations intend to increase the rate of HIV-survival and reduce non-HIV related ...
We estimated the proportion of HIV-positive adults who have any sexual contact without disclosure and the proportion of their ... Sex Without Disclosure of Positive HIV Serostatus in a US Probability Sample of Persons Receiving Medical Care for HIV ... Disclosing HIV seropositivity to significant others. AIDS. 1993;7:425-431. Crossref, Medline, Google Scholar. ... Marks G, Crepaz N. HIV-positive mens sexual practices in the context of self-disclosure of HIV status. J Acquir Immune Defic ...
HIV seropositivity in association with pityriasis lichenoides et varioliformis acuta. Clin Exp Dermatol. 1992 Jan. 17(1):36-7. ... In 1997, Smith et al reported a series of 5 patients with HIV infection in the early stage of disease, with CD4+ T-cell counts ... The first association between Mucha-Habermann disease and HIV infection was reported in 1991 by Ostlere et al. [28] A patient ... In addition to EBV, Toxoplasma gondii, and HIV, a number of other infectious agents have been implicated. The following ...
Infectious Diseases (except HIV/AIDS) (12495). *. Intensive Care and Critical Care Medicine (684) ... CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients. Simone Weber, Victoria Kehl ... CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients ... CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients ...
Cancer is a leading cause of death among people living with HIV/AIDS (PLWHA). We conducted a systematic review and meta- ... The high seropositivity of EBV-IgG was close to the prevalence reported earlier in the Chinese general population (97.6%)125. ... The clinical distribution of 994 HIV infection patients and statistical analysis of HIV and HCV co-infection. Int J Lab Med 34 ... Lifson, A. R. & Lando, H. A. Smoking and HIV: prevalence, health risks, and cessation strategies. Current HIV/AIDS reports 9, ...
Categories: HIV Seropositivity Image Types: Photo, Illustrations, Video, Color, Black&White, PublicDomain, CopyrightRestricted ...
In individuals with HIV infection, the seropositivity rate to T gondii is approximately 50-78% in certain areas of Western ... 6, 7] Infection with the human immunodeficiency virus (HIV) does not seem to effect T gondii seropositivity, and there does not ... Advanced HIV Disease: A Review of Diagnostic and Prophylactic Strategies * Neuro-HIV Multidisciplinary Platform for the ... T gondii seropositivity rates among patients with HIV infection vary from 10-45%. ...
Transmission of HIV During Invasive Procedures The risk of HIV transmission to an HCW after percutaneous exposure to HIV- ... Such circumstances would include notifying prospective patients of the HCWs seropositivity before they undergo exposure-prone ... HCWS WHOSE PRACTICES ARE MODIFIED BECAUSE OF HIV OR HBV STATUS HCWs whose practices are modified because of their HIV or HBV ... Identification of factors that may influence the likelihood of HIV or HBV transmission after exposure to HIV- or HBV-infected ...
Most HIV prevention literature portrays women as especially vulnerable to HIV infection because of biological susceptibility ... and Womens Vulnerability to HIV/AIDS, an article from American Journal of Public Health, Vol 100 Issue 3 ... Jewkes R, Dunkle K, Nduna M, et al.. Factors associated with HIV sero-positivity in young, rural South African men. Int J ... Rates of HIV-1 transmission within marriage in rural Uganda in relation to the HIV sero-status of the partners. AIDS. 1999;13(9 ...
Known human immunodeficiency virus (HIV) seropositivity or active hepatitis B or C infection. A history of hepatitis B or C is ...
... problem HIV/AIDS, identification of people living with HIV/AIDS (PLWHA), linking HIV/AIDS to immorality and other negative ... about HIV/AIDS and stigma in Sub-Saharan Africa. Literature about HIV/AIDS and stigma in Sub-Saharan Africa was systematically ... also enhances the number of HIV infections. More qualitative studies on HIV/AIDS stigma including stigma in health care ... cultural construction of HIV/AIDS, based on beliefs about contamination, sexuality, and religion, plays a crucial role and ...
Explore the impact of vaccination status, HIV/AIDS infection, and prematurity on ALRI outcomes. ... One death was noted in 16.3% and the determinants of death were HIV/AIDS seropositivity and severe emaciation. The still high ... The determinants of death identified were: HIV seropositivity and severe emaciation, excluding other factors: age, gender, ... The determinants of death are, as elsewhere, denutrition, HIV seropositivity, poverty, inadequate immunization coverage. ...
HIV Infections/ epidemiology/mortality , HIV Seropositivity , HIV Seroprevalence (Source: Medline) External Sources. Abstract ... The prevalence of HIV is predicted to stabilize at 10% in adults, resulting in a total number of people living with HIV at ... Demographic indicators from 1984 (the start of the HIV epidemic in Ethiopia) to 2024, including and excluding the HIV epidemic ... In a low-fertility urban society of Africa, this study shows the potential for the HIV/AIDS epidemic to turn the rate of ...
Burden of HIV/AIDS infection before and during the civil war in Somalia ... Lack of evidence of HTLV-II seropositivity in Somalia. AIDS Research, 1986, 2:161-162. ... The current HIV infection problem may be higher than the figures indicate. To date, Somalia has had an HIV infection rate ... Special report on HIV prevention. Geneva, United Nations Joint Programme on HIV/AIDS and World Health Organization, 2005 ( ...
There was a positive correlation between patient age and HAV seropositivity. The lowest rate of IgG positivity (6%) was in ... I included this study from Japan as a reminder that we should be vaccinating our HIV patients for HAV consistent with the most ... This study from Japan looked at seroprevalence of HAV-IgG antibody in 468 persons with HIV (PWH) in 2017. Also recorded was HAV ... recent CDC guidance [1] that now includes persons with HIV infection, MSM, IDU, persons who are homeless, persons with chronic ...
HIV infection diagnosed by HIV seropositivity and confirmed by Western blot.. - Concomitant or prior history of malignancy ...
They also conducted vigorous debates about the ethics of HIV seropositivity disclosure, in which they often demanded that ... HIV+) respondent to view acquiring HIV as connected to personal decisions? Second: cannot individuals from disadvantaged ... More common, however, are data such as those from Riers (2007a, b, unpublished) study of sixteen online support groups for HIV ... Mosack, K. E., Abbott, M., Singer, M., Weeks, M. R., & Rohena, L. (2005). If I didnt have HIV, Id be dead now: Illness ...
HIV seropositivity rates in outreach-based counseling and testing services: program evaluation. J Acquir Immune Defic Syndr Hum ... UK National Guidelines for HIV Testing 2008. British HIV Association; British Association of Sexual Health and HIV; British ... HIV testing in community settings in resource-rich countries: a systematic review of the evidence. HIV Med 2012;13:416-26. ... HIV Testing. Introduction. Lacking a cure or an effective vaccine for HIV, screening strategies are critical to reduce the ...
must be tested for HIV seropositivity and CD4 lymphocyte count to be eligible for the. study. ... medications within 6 weeks of enrolling; HIV-positive and below normal cluster of. differentiation 4 (CD4) lymphocytes (less ...

No FAQ available that match "hiv seropositivity"